T1	Participants 126 216	locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck
T2	Participants 614 732	130 patients with locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck (SCC H&N)
